Zynerba Pharmaceuticals Inc. (ZYNE) gained 19.81% or 1.07 to $6.47. It is approximately 4.18 million shares traded, which is 389.11% compare to the average total volume 1.07 million. The market cap of ZYNE is $136.32 million. The year to date change is 64.98%. The 52 week price range is from $2.75 to $12.5. Price of ZYNE have changed -4.42% during last week. It have changed 4.85% over last month, 45.16% over last 3 months, -31.30% over last 6 months and -32.33% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ZYNE is 5.09. It is -21.33% below current price. The 200-day Moving Averages for ZYNE is 6.39. It is -1.24% below current price. The 52-week High is 12.5. It is 93.20% from the current price. The 52-week Low is 2.75. It is -57.50% from current price.
There are some statistics of ZYNE. It is has market cap $136.32 million. The share outstanding is 21.07 million. The average volume is 1.07 million. The percent of top 15 Institution holding is 22.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ZYNE is -68.84%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ZYNE is -59.82%.